SCHEMBL15568942

SCHEMBL15568942

Cc1ccc2cc(-c3ccc(C(C)(C)O)cc3)[nH]c(=O)c2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS O95271 18/20 0.53
TNKS2 Q9H2K2 18/20 0.53
PARP1 P09874 18/20 0.53
PARP2 Q9UGN5 2/20 0.48
PARP3 Q9Y6F1 2/20 0.48
ADORA3 P0DMS8 1/20 0.48
SLC6A3 Q01959 1/20 0.48
PARP6 Q2NL67 1/20 0.48
PARP10 Q53GL7 1/20 0.48
TIPARP Q7Z3E1 1/20 0.48
PARP8 Q8N3A8 1/20 0.48
PARP12 Q9H0J9 1/20 0.48
PARP11 Q9NR21 1/20 0.48
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
NPC1 O15118 1/20 0.43
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
HPGD P15428 1/20 0.43
MAPK1 P28482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14867343 0.85 HPGD (0.57) TNKSTNKS2PARP1KDM4EMEN1
SCHEMBL15568327 0.85 TNKS (0.62) TNKSTNKS2PARP1PARP2PARP3
SCHEMBL15567497 0.85 TNKS (0.62) TNKSTNKS2PARP1PARP2PARP3
SCHEMBL15567337 0.83 TNKS (0.58) TNKSTNKS2PARP1PARP2PARP3
SCHEMBL14867282 0.83 KDM4E (0.48) TNKSTNKS2PARP1KDM4EMEN1
SCHEMBL14867268 0.80 KDM4E (0.48) TNKSTNKS2PARP1PARP2KDM4E
SCHEMBL28629567 0.80 KDM4E (0.59) TNKSTNKS2PARP1KDM4EMEN1
SCHEMBL30160749 0.80 KDM4E (0.59) TNKSTNKS2PARP1KDM4EMEN1
SCHEMBL15567849 0.79 TNKS (0.47) TNKSTNKS2PARP1PARP2PARP3
SCHEMBL4769828 0.78 KDM4E (0.63) TNKSTNKS2PARP1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2882714-B1 (AZA-)ISOQUINOLINONE DERIVATIVES MERCK PATENT GMBH (DE) 2019-11-13 EP claimed
US-9376433-B2 (AZA-)isoquinolinone derivatives MERCK PATENT GMBH (DE) 2016-06-28 US claimed
US-20150210686-A1 (AZA-)ISOQUINOLINONE DERIVATIVES MERCK PATENT GMBH (DE) 2015-07-30 US claimed
EP-2882714-A2 (AZA-)ISOQUINOLINONE DERIVATIVES Merck Patent GmbH (DE) 2015-06-17 EP claimed
WO-2014023390-A2 (AZA-)ISOQUINOLINONE DERIVATIVES MERCK PATENT GMBH (DE) 2014-02-13 WO claimed
EP-2882714-B1 (AZA-)ISOQUINOLINONE DERIVATIVES MERCK PATENT GMBH (DE) 2019-11-13 EP disclosed
US-9376433-B2 (AZA-)isoquinolinone derivatives MERCK PATENT GMBH (DE) 2016-06-28 US disclosed
US-20150210686-A1 (AZA-)ISOQUINOLINONE DERIVATIVES MERCK PATENT GMBH (DE) 2015-07-30 US disclosed
EP-2882714-A2 (AZA-)ISOQUINOLINONE DERIVATIVES Merck Patent GmbH (DE) 2015-06-17 EP disclosed
WO-2014023390-A2 (AZA-)ISOQUINOLINONE DERIVATIVES MERCK PATENT GMBH (DE) 2014-02-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150210686-A1 (AZA-)ISOQUINOLINONE DERIVATIVES TANK, TNKS, TDP1 TNKS 2/4885TNKS2 6/4885PARP1 39/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.